Skip to content

Nasdaq · CIK 0001304492

ATEX Anterix Inc.

Insider trading from SEC Form 4. Last filing 12 d ago.

Last 90 days

Net insider value
-$3.3M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
5
$3.3M by 4 insiders
Insiders on file
14
with a Form 4 at this company

Signals

Open-market buys and sells at Anterix Inc., scored.

ScoreSideInsiderValueSharesHoldings changePrice contextFiled
75Notablesell 4Scott A. Lang
President and CEO
$1.2M15,000-36%-
42Moderatesell 4Leslie B Daniels
director
$210k2,500-5%-
56Moderatesell 4Heather Martin
Chief Marketing Officer
$679k8,064-23%-
58Moderatesell 3Leslie B Daniels
director
$880k10,100-18%-
55Moderatesell 4Gena L Ashe
Chief Legal Officer & Corp Sec
$372k4,357-46%-
47ModeratesellMorgan E Obrien
Executive Chairman
$455k13,609-36%-
33WeakbuyMark Fleischhauer
director
$120k3,500--
31WeakbuyLeslie B Daniels
director
$66k2,000--
32WeaksellGena L Ashe
Chief Legal Officer & Corp Sec
$183k5,547-18%-

Transactions

The last 32 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2026Elena Marquez
Chief Financial Officer
FTax withholding
Common Stock
-1,325$81.75$108k16,83112 d ago
Sep 21, 2026Scott A. Lang
President and CEO
SOpen-market sale
Common Stock
-15,000$80.00$1.2M26,47019 d ago
Sep 10, 2026Leslie B Daniels
director
SOpen-market sale
Common Stock
-2,500$83.83$210k43,47730 d ago
Sep 9, 2026Heather Martin
Chief Marketing Officer
FTax withholding
Common Stock
-3,465$85.44$296k34,80730 d ago
Sep 10, 2026Heather Martin
Chief Marketing Officer
SOpen-market sale
Common Stock
-8,064$84.20$679k26,74330 d ago
Sep 8, 2026Gena L Ashe
Chief Legal Officer & Corp Sec
SOpen-market sale
Common Stock
-293$85.44$25k9,23833 d ago
Sep 3, 2026Leslie B Daniels
director
SOpen-market sale
Common Stock
-6,000$87.15$523k50,07733 d ago
Sep 8, 2026Gena L Ashe
Chief Legal Officer & Corp Sec
SOpen-market sale
Common Stock
-4,064$85.44$347k5,17433 d ago
Sep 4, 2026Leslie B Daniels
director
SOpen-market sale
Common Stock
-2,900$87.31$253k47,17733 d ago
Sep 4, 2026Leslie B Daniels
director
SOpen-market sale
Common Stock
-1,200$86.50$104k45,97733 d ago
Feb 28, 2025William Heard
director
AGrant or award
Common Stock
+1,887$0.00$01,887Mar 4, 2025
Jan 22, 2025Thomas R. Kuhn
director, other
AGrant or award
Stock Option (Right to Buy)derivative
+56,803$0.00$056,803Jan 24, 2025
Jan 17, 2025Scott A. Lang
President and CEO
AGrant or award
Stock Option (Right to Buy)derivative
+191,326$0.00$0191,326Jan 22, 2025
Jan 16, 2025Christopher Guttman-McCabe
Chief Reg & Comm Officer
AGrant or award
Stock Option (Right to Buy)derivative
+67,774$0.00$067,774Jan 21, 2025
Jan 16, 2025Gena L Ashe
Chief Legal Officer & Corp Sec
AGrant or award
Stock Option (Right to Buy)derivative
+37,275$0.00$037,275Jan 21, 2025
Jan 16, 2025Ryan Gerbrandt
Chief Operating Officer
AGrant or award
Stock Option (Right to Buy)derivative
+67,774$0.00$067,774Jan 21, 2025
Jan 16, 2025Timothy Gray
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+40,664$0.00$040,664Jan 21, 2025
Dec 26, 2024Thomas R. Kuhn
director, other
AGrant or award
Stock Option (Right to Buy)derivative
+61,804$0.00$061,804Dec 30, 2024
Dec 16, 2024Morgan E Obrien
Executive Chairman
SOpen-market sale
Common Stock
-13,609$33.44$455k23,973Dec 17, 2024
Dec 5, 2024Thomas R. Kuhn
director, other
AGrant or award
Common Stock
+6,474$0.00$010,372Dec 17, 2024
Dec 9, 2024Morgan E Obrien
Executive Chairman
MOption exercise
Common Stock
+90,000$25.00$2.3M113,973Dec 11, 2024
Dec 9, 2024Morgan E Obrien
Executive Chairman
FTax withholding
Common Stock
-76,391$34.05$2.6M37,582Dec 11, 2024
Dec 9, 2024Morgan E Obrien
Executive Chairman
MOption exercise
Stock Option (Right to Buy)derivative
-90,000$0.00$00Dec 11, 2024
Dec 5, 2024Mahvash Yazdi
director
AGrant or award
Common Stock
+5,002$0.00$018,640Dec 9, 2024
Dec 5, 2024Mark Fleischhauer
director
POpen-market purchase
Common Stock
+3,500$34.19$120k3,500Dec 9, 2024
Dec 5, 2024Thomas R. Kuhn
director, other
AGrant or award
Common Stock
+6,574$0.00$010,472Dec 9, 2024
Dec 5, 2024Leslie B Daniels
director
AGrant or award
Common Stock
+5,002$0.00$046,712Dec 9, 2024
Dec 5, 2024Jeffrey A Altman
director, owner
AGrant or award
Common Stock, par value $0.0001 per share ("Common Stock")
+5,002$0.00$07,649Dec 9, 2024
Dec 5, 2024Mark Fleischhauer
director
AGrant or award
Common Stock
+5,002$0.00$08,502Dec 9, 2024
Nov 20, 2024Leslie B Daniels
director
POpen-market purchase
Common Stockindirect: By IRA
+2,000$32.75$66k2,000Nov 22, 2024
Nov 19, 2024Gena L Ashe
Chief Legal Officer & Corp Sec
SOpen-market sale
Common Stock
-5,547$33.00$183k26,083Nov 20, 2024
Nov 15, 2024Christopher Guttman-McCabe
Chief Reg & Comm Officer
FTax withholding
Common Stock
-3,447$31.93$110k48,288Nov 19, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ATEX insider trading: Anterix Inc. | InsiderTell